Highlights of the Program
2 days business program:
Learn from real-world case studies by industry leaders.
SHOWCASING INNOVATION:
Discover the latest technology and techniques from across the industry.
leaders talk:
Hear from top-level experts about how to stay ahead in a fast-changing industry.
MULTIPLE STREAMS:
A business program that is multi-disciplinary, giving you a broad view of the industry.
SMART TECHNOLOGIES:
Explore the latest smart and AI-driven solutions, and see how they can be used in your business.
roundtable discussion:
Join talks with industry peers. Share ideas, make connections, and find new partners.
Program
Day 1 :
MONDAY, JUNE 29, 2026
08:00 - 09:00
REGISTRATION AND MORNING REFRESHMENTS
09:00 - 09:10
OPENING ADDRESS
09:10 - 09:35
SUSTAINABILITY OR COMPLIANCE? HOSPITALS DARE TO ASK: CAN WE REPROCESS MEDICAL DEVICES?


Caroline De Mooij
Rijnstate
- Balancing hospital sustainability goals with MDR Article 17 requirements for single-use reprocessing
- Weighing operational costs and feasibility as hospitals question full compliance pathways
- Exploring legal and safe alternatives for reprocessing non-critical devices under sustainable models
09:35 - 09:40
Q&A SESSION ON MDR COMPLIANCE AND SUSTAINABLE DEVICE REUSE
09:40 - 10:05
THE ROLE OF NANOPARTICLES IN ENHANCING STERILISATION EFFICACY FOR MEDICAL DEVICES


Mahsa Shokri
Tabriz University
- Exploring antimicrobial properties of nanoparticles that enhance sterilisation effectiveness
- Discussing innovative nanoparticle coatings that improve device safety and longevity
- Analysing challenges in nanoparticle sterilisation and future research opportunities
10:05 - 10:10
Q&A SESSION ON NANOPARTICLE APPLICATIONS IN STERILISATION
10:10 - 10:40
SPEED NETWORKING SESSION
- Exchange business cards and get connected in short one-to-one meetings
- Start the conversation to arrange a more formal meeting later on in the conference
- Share your professional background and discuss your biggest business issues – don't forget your business cards!
10:40 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:00 - 11:30
PANEL DISCUSSION ON STERILISATION
11:30 - 11:55
QUALITY FIRST: CONVEYOR AUTOMATION AND DOSIMETRY IN RADIATION STERILISATION


Dirk Voessing
MSB Maschinen- & Stahlbau GmbH & Co.KG
- Ensuring dose reproducibility through conveyor automation and precise product positioning
- Enabling traceability and GMP compliance with automated dosimeter handling and batch-linked data
- Supporting validation and uptime with mechanically robust, audit-ready sterilisation systems
11:55 - 12:00
Q&A SESSION ON RADIATION STERILISATION, AUTOMATION, AND QUALITY CONTROL
12:00 - 12:25
CHLORINE DIOXIDE GAS STERILISATION AND MATERIAL IMPACTS


Emily Lorcheim
ClorDiSys Solutions
- Explaining how chlorine dioxide gas sterilises and how it differs from other common methods
- Outlining material compatibility findings and insights from recent technical studies
- Highlighting packaging types that work with ClO₂ and results from collaborative testing
12:25 - 12:30
Q&A SESSION ON MATERIAL & PACKAGING EFFECTS OF CLO₂ STERILISATION
12:30 - 13:30
NETWORKING LUNCH AND VISITING THE STERILISATION EXHIBITION
13:30 - 13:55
CSSD’S IN THE MIDDLE EAST AND AFRICA — THEORY VS PRACTISE


Peter Newson
ParaSure Ltd
- Contrasting international standards with regional CSSD implementation and accountability gaps
- Examining shared practices and market-specific pressures shaping sterilisation roles in MEA
- Promoting excellence through local education, infection control alignment, and leadership
13:55 - 14:00
Q&A SESSION ON MEA ALIGNMENT WITH GLOBAL STANDARDS
14:00 - 14:25
MEDACCRED – SUSTAINABLE STANDARDIZED APPROACH TO TECHNICAL ASSESSMENTS OF CRITICAL PROCESSES: WHAT’S NEW?


Kimberly Patton
PRI | The Performance Review Institute
- Introducing the MedAccred model and its impact on supplier oversight and global compliance culture
- Incorporating FDA pilots, ISO 11137-1 updates, and notified body perspectives into audit criteria
- Encouraging engagement through a formal call to action for participation in the MedAccred program
14:25 - 14:30
Q&A SESSION ON ADVANCING GLOBAL STANDARDS THROUGH MEDACCRED
14:30 - 14:55
WHERE TO MOVE FROM ETO STERILISATION IN MEDICAL DEVICES


Petra Elischer
Hart Biologicals Limited
- Exploring alternatives like VHP, NO₂, ScCO₂, O₃, and LTP for replacing EtO sterilisation
- Addressing regulatory requirements for submissions during sterilisation transitions
- Assessing material compatibility with emerging low-temperature sterilisation methods
14:55 - 15:00
Q&A SESSION ON MOVING BEYOND ETO: METHODS, RISKS & REGULATORY IMPACT
15:00 - 15:30
AFTERNOON COFFEE BREAK IN THE EXHIBIT AREA
15:30 - 15:55
STERILISATION VALIDATION: IMPORTANCE OF A FULLY VALIDATED IFU


Enrico Allegra
Test Labs
- Exploring regulatory requirements for sterilisation validation under MDR and FDA
- Discussing standards, methods, and insights from regulatory submission experiences
- Reviewing common and emerging sterilisation methods, including low-temp H₂O₂
15:55 - 16:00
Q&A SESSION ON STERILISATION VALIDATION REQUIREMENTS
16:00 - 16:30
RESERVED PRESENTATION
16:30 - 16:55
SELECTING THE OPTIMAL STERILISATION METHOD THROUGH RAPID PREDICTION OF LONG-TERM MATERIAL AGEING PROPERTIES


Nazli Ozdemir
Gulsine ltd.
- Comparing how various sterilisation methods drive unique degradation pathways in polymers and device materials
- Predicting functional lifespan and failure risk using ageing physics and accelerated material modelling
- Applying A2P2 to select optimal sterilisation methods, minimize revalidation, and improve safety and shelf life
16:55 - 17:00
Q&A SESSION ON AGEING PREDICTION AND STERILISATION SELECTION STRATEGIES
17:00 - 18:00
NETWORKING DRINKS RECEPTION
Day 2 :
TUESDAY, TUESDAY, JUNE 30, 2026
08:30 - 09:00
MORNING REFRESHMENTS
09:00 - 09:10
OPENING ADDRESS
09:10 - 09:35
REPROCESSING REUSABLE MEDICAL DEVICES IN THE LAND DOWN UNDER: AUSTRALIA’S PERSPECTIVE, CHALLENGES AND BEST PRACTICE


Darren Martin
Bendigo Health
- Comparing Australia's reprocessing landscape to Europe's across governance and regulatory domains
- Navigating challenges of national consistency, remote delivery, and fragmented health structures
- Prioritising sustainability through smarter water use, reduced waste, and reusable innovations
- Advancing reprocessing with automation, leadership focus, and infrastructure-driven quality
09:35 - 09:40
Q&A SESSION ON REPROCESSING SYSTEMS IN GEOGRAPHICALLY DIVERSE REGIONS
09:40 - 10:05
THE PARADIGM SHIFT IN STERILISATION: SCALABLE NITRIC OXIDE SYSTEM


Megan Frost
Sterile State
- Exploring nitric oxide as a novel, self-sterilising packaging and medical device solution
- Highlighting broad material compatibility, including medical polymers and human tissue
- Replacing ethylene oxide with a scalable NO-based gas sterilisation alternative
10:05 - 10:10
Q&A SESSION ON NITRIC OXIDE STERILISATION TECHNOLOGY
10:10 - 10:35
FAILURE INVESTIGATION FOR ROUTINE /STERILIZATION REVALIDATION FAILURE


Chithra Muruthi
B. Braun Group
- Optimising sterilisation processes to reduce environmental impacts and resource use
- Recycling and reusing ETO gases to minimise emissions and fresh ETO consumption
- Implementing energy-efficient equipment to lower the carbon footprint of sterilisation
10:35 - 10:40
Q&A SESSION ON SUSTAINABLE STERILISATION PRACTICES
10:40 - 11:00
MORNING COFFEE BREAK IN THE EXHIBIT AREA
11:00 - 11:25
UV-C LED DISINFECTION VS. MANUAL CHEMICAL METHODS FOR ULTRASOUND PROBES


Hannah Siwe
Zaparay
- Comparing UV-C LED disinfection to manual chemical methods in a hospital study
- Assessing efficacy across abdominal, transvaginal, and transrectal ultrasound probes
- Exploring UV-C LED's potential to reduce human error and environmental impacts
11:25 - 11:30
Q&A SESSION ON UV-C LED DISINFECTION FOR MEDICAL DEVICES
11:30 - 11:55
ARE DIFFERENT STERILISATION TECHNOLOGIES LEADING TO SIGNIFICANT CHANGES IN THE EXTRACTABLES PROFILE OF POLYMERS USED IN PHARMACEUTICAL PACKAGING OR IN MEDICAL DEVICES?


Frank De Smedt
DyFrNd
- Understanding core principles of extractables and leachables studies for packaging and devices
- Analysing the impact of sterilisation on the E&L profile of polymer-based materials
- Conducting post-sterilisation residual testing to evaluate compliance and material safety
11:55 - 12:00
Q&A SESSION ON E&L IMPACTS OF STERILISATION TECHNOLOGIES
12:00 - 12:25
INTERPRETING AND APPLYING THE A₀ CONCEPT IN THERMAL DISINFECTION OF ENDOSCOPE REPROCESSORS


Daniel Parra
Endoval Ltd.
- Explaining the A₀ concept from EN ISO 15883 and its application in 80°C thermal disinfection cycles
- Calculating, monitoring, and verifying A₀ values in washer-disinfectors for flexible endoscopes
- Overcoming technical challenges to ensure consistent and compliant thermal disinfection outcomes
12:25 - 12:30
Q&A SESSION ON A₀ APPLICATION AND THERMAL DISINFECTION STANDARDS
12:30 - 13:30
NETWORKING LUNCH AND VISITING THE STERILISATION EXHIBITION
13:30 - 13:55
INFECTION PREVENTION IN CARDIAC SURGERY: STERILISATION OF PERFUSION CIRCUITS AND EQUIPMENT


Ralph Kodjovi
Adjanou Perfusion Solution, Inc.
- Strengthening perfusionists’ understanding of sterilisation protocols and contamination risks
- Standardising sterile setup and handling techniques through targeted training and education
- Reducing surgical site infections through improved circuit management and aseptic practices
13:55 - 14:00
Q&A SESSION ON PERFUSION STERILISATION AND INFECTION CONTROL
14:00 - 14:25
PITFALLS OF INTERNATIONAL STANDARDS RELATED TO STERILE SUPPLY


Jan Huijs
HEART Consultancy
- Revealing how well-intended global standards can unintentionally undermine sterilisation efforts in LMICs
- Exposing the disconnect between complex standards and the realities of infrastructure and budget constraints
- Proposing a globally appropriate framework to ensure effective sterile supply without overburdening systems
14:25 - 14:30
Q&A SESSION ON CONTEXTUALISING STERILISATION STANDARDS FOR GLOBAL HEALTH
14:30 - 14:55
BEYOND CLEANLINESS: ADVANCED STERILISATION STRATEGIES FOR SURGICAL SUCCESS AND ZOONOTIC RISK MITIGATION


Tarikul Islam
Bangladesh Livestock Research Institute
- Preserving instrument integrity and diagnostic accuracy by eliminating biofilms, spores, and contaminating microbes
- Preventing zoonotic transmission from animal patients to clinical staff through rigorous, validated sterilisation practices
- Supporting immune recovery and sepsis prevention by ensuring true sterility beyond standard disinfection
14:55 - 15:00
Q&A SESSION ON STERILISATION, BIOSAFETY, AND ZOONOTIC RISK CONTROL
15:00 - 15:25
FROM COMPLIANCE TO PERFORMANCE: ADVANCING PATIENT SAFETY THROUGH MODERN CSSD PRACTICE


David Lee
M42 Health
- Elevating CSSD practice beyond baseline compliance by applying performance metrics and safety-driven quality indicators
- Strengthening reliability through automation, digital instrument tracking, and modern decontamination technologies
- Translating real-world CSSD change efforts into scalable lessons that improve outcomes without overburdening staff
15:25 - 15:30
Q&A SESSION ON PERFORMANCE-DRIVEN CSSD TRANSFORMATION
15:30 - 15:45
FEEDBACK & RAFFLE DRAW
15:45 - 16:00
CLOSING REMARKS
Become a Speaker & Join the Conversation
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.